Publication Catalogue

Publications of the Department of Epidemiology and Health Promotion 2002

A. Original articles and reviews

  1. Aalto AM, Härkäpää K, Aro AR, Rissanen P: Ways of coping with asthma in everyday life: validation of an asthma-specific coping scale. J PSYCHOSOM RES 2002;53:1061-1069.
  2. Absetz P, Aro AR, Rehnberg G, Sutton SR: Experience with breast cancer, prescreening perceived susceptibility, and the psychological impact of screening. Psycho-Oncology 2002;10:1-14.
  3. Absetz P, Aro AR, Sutton SR: Factors associated with breast cancer risk perception and psychological distress in a representative sample of middle-aged Finnish women. Anxiety, Stress and Coping 2002;15:61-73.
  4. Al-Lawati JA, Al-Riyami AM, Mohammed AJ, Jousilahti P: Increasing prevalence of diabetes mellitus in Oman. Diabet Med 2002;19:954-957.
  5. Anttila T, Helkala EL, Kivipelto M, Hallikainen M, Alhainen K, Heinonen H, Mannermaa A, Tuomilehto J, Soininen H, Nissinen A: Midlife income, occupation, APOE status, and dementia. Neurology 2002;59:887-893.
  6. Aromaa A, Knekt P, Reunanen A, Tuomilehto J, Jousilahti P, Vartiainen E, Nissinen A, Prospective SC: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
  7. Balder HF, Tan F, Brants H, Dixon LB, Virtanen M, Krogh V, Terry P, Pietinen P, Berrino F, Wolk A, Hartman A, Van den Brandt PA, Goldbohm RA: Dietscan: a common approach for analysing dietary patterns. IARC Sci Publ 2002;156:27-29.
  8. Barengo NC, Nissinen A, Tuomilehto J, Pekkarinen H: Twenty-five-year trends in physical activity of 30- to 59-year-old populations in eastern Finland. Med Sci Sports Exerc 2002;34:1302-1307.
  9. Barker DJP, Eriksson JG, Forsen T, Osmond C: Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002;31:1235-1239.
  10. Barker DJP, Forsen T, Eriksson JG, Osmond C: Growth and living conditions in childhood and hypertension in adult life: a longitudinal study. J Hypertens 2002;20:1951-1956.
  11. Bots ML, Elwood PC, Nikitin Y, Salonen JT, de Concalves F, Inzitari D, Sivenius J, Trichopoulou A, Tuomilehto J, Koudstaal PJ, Grobbee DE: The EUROSTROKE cohorts: a short description and data analytical approach. J Epidemiol Community Health 2002;56(Suppl 1):i2-i7.
  12. Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire CA, Inzitari D, Sivenius J, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE: Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J EPIDEMIOL COMMUNITY HEALTH 2002;56(Suppl 1):i19-i25.
  13. Bots ML, Elwood PC, Salonen JT, Freire CA, Sivenius J, Di CA, Nikitin Y, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE: Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKe: a collaborative study among research centres in Europe. J EPIDEMIOL COMMUNITY HEALTH 2002;56(Suppl 1):i14-i18.
  14. Bots ML, Nikitin Y, Salonen JT, Elwood PC, Malyutina S, Freire CA, Sivenius J, Di CA, Lagiou P, Tuomilehto J, Koudstaal PJ, Grobbee DE: Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J EPIDEMIOL COMMUNITY HEALTH 2002;56(Suppl 1):i8-i13.
  15. Bots ML, Salonen JT, Elwood PC, Nikitin Y, Freire CA, Inzitari D, Sivenius J, Trichopoulou A, Tuomilehto J, Koudstaal PJ, Grobbee DE: Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project. J EPIDEMIOL COMMUNITY HEALTH 2002;56(Suppl 1):i25-i29.
  16. Bulpitt CJ, Beckett NS, Fletcher AE, Thijs , Staessen JA, Dumitrascu DL, Forette F, Leonetti G, Nachev C, Tuomilehto J, Fagard RH: Withdrawal from treatment in the SYST-EUR Trial. J Hypertens 2002;20:339-346.
  17. Cakir B, Pankow JS, Salomaa V, Couper D, Morris TL, Brantley KR, Hiller KM, Heiss G, Weston BW: Distribution of Lewis (FUT3) genotype and allele: frequencies in a biethnic United States population. ANN HEMATOL 2002;81:558-565.
  18. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group, Eriksson J: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077.
  19. Clarke R, Homocysteine Studies Collaboration Group, Alfthan G, Tuomilehto J: Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002;288:2015-2022.
  20. Colbert LH, Hartman TJ, Tangrea JA, Pietinen P, Virtamo J, Taylor PR, Albanes D: Physical activity and lung cancer risk in male smokers. Int J Cancer 2002;98:770-773.
  21. Dahlman I, Eaves IA, Kosoy R, Heward J, Gough SCL, Allahabadia A, Franklyn JA, Tuomilehto J, Tuomilehto-Wolf E, Cucca F, Guja C, Ionescu-Tirgoviste C, Stevens H, Carr P, Nutland S, Mc KP, Shield JP, Wang W, Cordell HJ, Walker N, Todd JA, Concannon P: Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30:149-150.
  22. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE Study Group, Tuomilehto J, Sarti C, Ylihärsilä H: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
  23. Eriksson J: Growth and coronary heart disease in adult life. Cardiovascular Reviews & Reports 2002;23:557-560.
  24. Eriksson J, Forsen T: Unravelling the fetal origins hypothesis (correspondence). Ann Med 2002;360:2072.
  25. Eriksson J, Forsen T, Tuomilehto J, Osmond C, Barker D: Size at birth, fat-free mass and resting metabolic rate in adult life. Horm Metab Res 2002;34:72-76.
  26. Eriksson J, Forsen T, Tuomilehto J, Jaddoe VWV, Osmond C, Barker DJP: Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia 2002;45:342-348.
  27. Eriksson JG, Forsen T: Childhood growth and coronary heart disease in later life. Ann Med 2002;34:157-161.
  28. Eriksson JG, Lindi V, Uusitupa M, Forsen TJ, Laakso M, Osmond C, Barker DJP: The effects of the Pro12Ala polymorphism of the peroxisome proliferator - activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 2002;51:2321-2324.
  29. Fagerlund R, Melén K, Kinnunen L, Julkunen I: Arginine/lysine-rich NLS mediates interactions between dimeric STATs and importin 5. J Biol Chem 2002;277:30072-30078.
  30. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, Silander K, Valle TT, Buchanan TA, Tuomilehto J, Bergman RN, Boehnke M, Collins FS: Variation in three single nucleotide polymorphisms in the Calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 2002;51:1644-1648.
  31. Fletcher AE, Bulpitt CJ, Thijs L, Tuomilehto J, Antikainen R, Bossini A, Browne JD, Kawecka-Jaszcz K, Kivinen P, Sarti C, Terzoli L, Staessen JA, Syst-Eur Trial Investigators: Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial. J Hypertens 2002;20:2069-2079.
  32. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhager WH: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002;162:2046-2052.
  33. Fuentes RM, Notkola IL, Shemeikka S, Tuomilehto J, Nissinen A: Tracking of systolic blood pressure during childhood: a 15-year follow-up population-based family study in eastern Finland. J Hypertens 2002;20:195-202.
  34. Fuentes RM, Notkola IL, Shemeikka, Tuomilehto J, Nissinen A: Familial aggregation of body mass index: A population-based family study in Eastern Finland. Horm Metab Res 2002;34:406-410.
  35. Fuentes RM, Perola M, Nissinen A, Tuomilehto J: ACE gene and physical activity, blood pressure, and hypertension: a population study in Finland. J APPL PHYSIOL 2002;92:2508-2512.
  36. Fullerton SM, Clark AG, Weiss KM, Taylor SL, Stengård JH, Salomaa V, Boerwinkle E, Nickerson DA: Sequence polymorphism at the huma apolipoprotein All gen (APOA2): unexpected deficit of variation in an African-American sample. Hum Genet 2002;111:75-87.
  37. Goedecke V, Crane AM, Jaakkola E, Kaluza W, Laiho K, Weeks DE, Wilson J, Kauppi M, Kaarela K, Tuomilehto J, Wordsworth BP, Brown MA: Interleukin 10 polymorphisms in ankylosing spondylitis. Genes and Immunity 2002;4:74-76.
  38. Guo SW, Tuomilehto J: Preferential transmission of type 1 diabetes from parents to offspring: Fact or artifact? Genet Epidemiol 2002;23:323-334.
  39. Haapala I, Hirvonen A, Niskanen L, Uusitupa M, Kröger H, Alhava E, Nissinen A: anthropometry, bioelectrical impedance and dual-energy X-ray absorptiometry in the assessment of body composition in elderly Finnish women. Clinical Physiology and Functional Imaging 2002;22:383-391.
  40. Hakala P, Rimpelä A, Salminen J, Virtanen SM, Rimpelä M: Back, neck, and shoulder pain in Finnish adolescents: national cross sectional surveys. BMJ 2002;325:743.
  41. Harrela M, Qiao Q, Koistinen R, Tuomilehto J, Nissinen A, Seppälä M, Leinonen P: High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 2002;34:144-149.
  42. Hartman TJ, Taylor PR, Alfthan G, Fagerstrom R, Virtamo J, Mark SD, Virtanen M, Barret MJ, Albanes D: Toenail selenium concentration and lung cancer in male smokers (Finland). Cancer Causes Control 2002;13:923-928.
  43. Haukkala A: Socio-economic differences in hostility measures - a population based study. Psychology and Health 2002;17:191-202.
  44. Helasoja V, Prättälä R, Dregval L, Pudule I, Kasmel A: Late response and item nonresponse in the FINBALT Health Monitor Survey. European Journal of Public Health 2002;12:117-123.
  45. Hemilä H, Kaprio J, Albanes D, Heinonen OP, Virtamo J: Vitamin C, vitamin E, and beta-carotene in relation to common cold incidence in male smokers. Epidemiology 2002;13:32-37.
  46. Hemmilä HM, Keinänen-Kiukaanniemi SM, Levoska S, Puska P: Long-term effectiveness of bone-setting, light exercise therapy, and physiotherapy for prolonged back pain: A randomized controlled trial. J MANIPULATIVE PHYSIOL THER 2002;25:99-104.
  47. Hiltunen TP, Hannila-Handelberg T, Petäjäniemi N, Kantola I, Tikkanen I, Virtamo J, Gautschi I, Schild L, Kontula K: Liddle's syndrome associated with a point mutation in the extracellular domain of the epithelial sodium channel gamma subunit. J Hypertens 2002;20:2383-2390.
  48. Hoffmann K, Boeing H, Dufour A, Volatier JL, Telman J, Virtanen M, Becker W, De Henauw S, EFCOSUM Group: Estimating the distribution of usual dietary intake by short-term measurements. Eur J Clin Nutr 2002;56(Suppl 2):S53-S52.
  49. Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST, Pietinen P, Taylor PR, Virtamo J, Albanes D: Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the Alpha-Tocopherol, Beta-Carotene Cohort Study. Am J Epidemiol 2002;156:536-547.
  50. Houterman S, Boshuizen HC, Verschuren WMM, Giampaoli S, Nissinen A, Menotti A, Kromhout D: Predicting cardiovascular risk in the elderly in different European countries. Eur Heart J 2002;23:294-300.
  51. Hu G, Pekkarinen H, Hänninen O, Yu ZJ, Tian HG, Guo ZY: Commuting, leisure time physical activity and cardiovascular risk factors in China. Med Sci Sports Exerc 2002;34:234-238.
  52. Hu G, Pekkarinen H, Hänninen O, Yu Z, Tian H, Guo Z, Nissinen A: Physical activity during leisure and commuting in Tianjin, China. BULL WORLD HEALTH ORGAN 2002;80:933-938.
  53. Hu G, Pekkarinen H, Hänninen O, Guo ZY, Tian HG: Risk factors comparison between Chinese overweight and normal weight adults. BR J NUTR 2002;88:91-97.
  54. Hu G, Qiao Q, Tuomilehto J: Nonhypertensive cardiac effects of a high salt diet. Current Hypertension Reports 2002;4:13-17.
  55. Hyppönen E, Järvelin MR, Virtanen S: Seasonality of birth in patients with type 1 diabetes - correspondence. Lancet 2002;359:1247-1248.
  56. Jakovljevic D, Tuomilehto J: Use of selective serotonin reuptkae inhibitors and the risk of stroke: Is there reason for concern? Stroke 2002;33:1448-1449.
  57. Jallinoja P: Ethics of clinical genetics: the spirit of the profession and trials of suitability from 1970 to 2000. Critical Public Health 2002;12:103-118.
  58. Johnson GCL, Payne F, Nutland S, Stevens H, Tuomilehto-Wolf E, Tuomilehto J, Todd JA: A comprehensive, statistically powered analysis of GAD2 in type 1 diabetes. Diabetes 2002;51:2866-2870.
  59. Jousilahti P, Helakorpi S: Prevalence of exposure to environmental tobacco smoke at work and at home - 15 -year trends in Finland. Scand J Work Environ Health 2002;28(suppl 2):16-20.
  60. Jousilahti P, Patja K, Salomaa V: Environmental tobacco smoke and the risk of cardiovascular disease. Scand J Work Environ Health 2002;28(suppl 2):41-51.
  61. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T: The association of sensitive systemic inflammation markers with bronchial asthma. ANN ALLERGY ASTHMA IMMUNOL 2002;89:381-385.
  62. Jousilahti P, Vartiainen E, Alho H, Poikolainen K, Sillanaukee P: Opposite associations of carbohydrate-deficient transferrin and gamma-glutamyltransferase with prevalent coronary heart disease. Arch Intern Med 2002;162:817-821.
  63. Kaarisalo MM, Immonen-Räihä P, Marttila RJ, Salomaa V, Torppa J, Tuomilehto J, FINMONICA MI: The risk of stroke following coronary revascularization - population-based long-term follow-up study. Scandinavian Cardiovascular Journal 2002;36:231-236.
  64. Kajantie E, Phillips DI, Andersson S, Barker DJP, Dunkel L, Forsen T, Osmond C, Tuominen J, Wood PJ, Eriksson J: Size at birth, gestational age and cortisol secretion in adult life: foetal programming of both hyper- and hypocortisolism? CLIN ENDOCRINOL (OXF) 2002;57:635-641.
  65. Karvonen M, Moltchanova E, Viik-Kajander M, Moltchanov V, Rytkönen M, Kousa A, Tuomilehto J: Regional inequality in the risk of acute myocardial infarction in Finland: A case study of 35- to 74-year-old men. Heart Drug 2002;2:51-60.
  66. Kastarinen M, Puska P, Korhonen M, Mustonen J, Salomaa V, Sundvall J, Tuomilehto J, Uusitupa M, Nissinen A, LIHEF Study Group: Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland. J Hypertens 2002;20:2505-2512.
  67. Kastarinen M, Tuomilehto J, Vartiainen E, Jousilahti P, Nissinen A, Puska P: Smoking trends in hypertensive and normotensive Finns during 1982-1997. J Hum Hypertens 2002;16:299-303.
  68. Kautiainen S, Rimpelä A, Vikat A, Virtanen SM: Secular trends in overweight and obesity among Finnish adolescents in 1977-1999. Int J Obes Relat Metab Disord 2002;26:544-552.
  69. Kemppainen U, Tossavainen K, Vartiainen E, Pantelejev V, Puska P: Smoking patterns among ninth-grade adolescents in the Pitkäranta district (Russia) and in eastern Finland. PUBLIC HEALTH NURS 2002;19:30-39.
  70. Kiiskinen U, Vartiainen E, Puska P, Pekurinen M: Smoking-related costs among 25 to 59 year-old males in a 19-year individual follow-up. European Journal of Public Health 2002;12:145-151.
  71. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H: Use of oral antimicrobials decreases serum enterolactone concentration. EPIDEMIOL REV 2002;155:472-477.
  72. Kiuru-Enari S, Somer H, Seppäläinen AM, Notkola IL, Haltia M: Neuromuscular pathology in hereditary gelsolin amyloidosis. J NEUROPATHOL EXP NEUROL 2002;61:565-571.
  73. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H: Apolipoprotein E 4 allele, elevated midlife total cholesterol level and high midlife systolic blood pressure are independent risk factors for late-life alzheimer disease. Ann Intern Med 2002;137:149-155.
  74. Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H: Hypertension and hypercholesterolaemia as risk factors for alzheimer's disease. CNS drugs 2002;16:435-444.
  75. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J: The Finnish Cancer Registry as follow-up source of a large trial cohort. ACTA ONCOL 2002;41:381-388.
  76. Korhonen P, Palmgren J: Effect modification in a randomized trial under non-ignorable non-compliance: an application to the alpha-tocopherol beta-carotene study. Journal of the Royal Statistical Society. Series C, Applied statistics 2002;51:115-133.
  77. Kulathinal SB, Gasbarra D: Testing Equality of Cause-Specific Hazard Rates Corresponding to m Competing Risks Among K Groups. Lifetime Data Analysis 2002;8:147-161.
  78. Kulathinal SB, Kuulasmaa K, Gasbarra D: Estimation of an errors-in-variables regression model when the variances of the measurement errors vary between the observations. Stat Med 2002;21:1089-1101.
  79. Laaksonen M, Lahelma E, Prättälä R: Associations among health-related behaviours: sociodemographic variation in Finland. SOZ PRAVENTIVMED 2002;47:225-232.
  80. Laatikainen T, Alho H, Vartiainen E, Jousilahti P, Sillanaukee P, Puska P: Self-reported alcohol consumption and association to carbohydrate-deficient transferrin and gamma-glutamyltransferase in a random sample of the general population in the Republic of Karelia, Russia and in the North Karelia, Finland. Alcohol Alcohol 2002;37:282-288.
  81. Laatikainen T, Delong L, Pokusajeva S, Uhanov M, Vartiainen E, Puska P: Changes in cardiovascular risk factors and health behaviours from 1992 to 1997 in the Republic of Karelia, Russia. European Journal of Public Health 2002;12:37-43.
  82. Lahti-Koski M, Pietinen P, Heliövaara M, Vartiainen E: Associations of body mass index and obesity with physical activity, food choices, alcohol intake, and smoking in the 1982-1997 FINRISK Studies. Am J Clin Nutr 2002;75:809-817.
  83. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
  84. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT: Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 2002;23:706-713.
  85. Lakka HM, Salonen JT, Tuomilehto J, Kaplan GA, Lakka TA: Obesity and weight gain are associated with increased incidence of hyperinsulinemia in non-diabetic men. Horm Metab Res 2002;34:492-498.
  86. Laukkanen E, Shemeikka S, Notkola IL, Koivumaa-Honkanen H, Nissinen A: Externalizing and internalizing problems at school as signs of health-damaging behaviour and incipient marginalization. Health Promotion International 2002;17:139-146.
  87. Lilja HE, Soro A, Ylitalo K, Nuotio I, Viikari JSA, Salomaa V, Vartiainen E, Taskinen MR, Peltonen L, Pajukanta P: A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster. Atherosclerosis 2002;164:103-111.
  88. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, Albanes D: Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002;11:1095-1099.
  89. Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S, LIFE Study Group, Tuomilehto J, Sarti C: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:1004-1010.
  90. Lindi VI, Uusitupa MJ, Lindström J, Louheranta A, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Tuomilehto J, The Finnish Diabetes Prevention Study Group: Association of the Pro12A1a polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 2002;51:2581-2586.
  91. Lobnig BM, Chantelau E, Vidgren G, Van Landeghem AA, Kinnunen L, Tuomilehto-Wolf E: HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases. EHPS Newsletter 2002;28:217-21.
  92. Malila N, Taylor PR, Virtanen MJ, Korhonen P, Huttunen JK, Albanes D, Virtamo J: Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). Cancer Causes Control 2002;13:617-623.
  93. Malila N, Virtamo J, Virtanen M, Pietinen P, Albanes D, Teppo L: Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers. Eur J Clin Nutr 2002;56:615-621.
  94. Mattila P, Tarkkanen J, Saxen H, Pitkäniemi J, Karvonen M, Tuomilehto J, Childhood Diabetes in Finland (DiMe) Study Group: Predisposition to atopic symptoms to inhaled antigens may protect from childhood type 1 diabetes. Diabetes Care 2002;25:865-868.
  95. Michaud DS, Hartman TJ, Taylor PR, Pietinen P, Alfthan G, Virtamo J, Albanes D: No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1505-1506.
  96. Michaud DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, Albanes D: Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br J Cancer 2002;87:960-965.
  97. Moons KGM, Bots ML, Salonen JT, Elwood PC, Freire CA, Nikitin Y, Sivenius J, Inzitari D, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE: Prediction of stroke in the general population in Europe (EUROSTROKE): is there a role for fibrinogen and electrocardiography? J EPIDEMIOL COMMUNITY HEALTH 2002;56:i30-i36.
  98. Muntoni SA, Karvonen M, Muntoni S, Tuomilehto J: Seasonality of birth patients with type 1 diabetes (correspondence). Lancet 2002;359:1246.
  99. Nakagami T, Qiao Q, Tuomilehto J, Borch-Johnsen K, DECODA Study Group: The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. DIABETES RES CLIN PRACT 2002;55:35-43.
  100. Nielsen SE, Freese R, Kleemola P, Mutanen M: Flavonoids in human urine as biomarkers for intake of fruits and vegetables. Cancer Epidemiol Biomarkers Prev 2002;11:459-466.
  101. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, de Leeuw PW, Jääskivi M, Leonetti G, Nachev C, O'Brien ET, Parati G, Rodicio JL, Roman E, Sarti C, Tuomilehto J: Predictive value of clinic and ambulatory heart rate for mortality in elderly subject with systolic hypertension. Arch Intern Med 2002;162:2313-2321.
  102. Pelkonen M, Notkola IL, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A: Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow-up study among Finnish cohorts of the Seven Countries Study (Authors' reply). Thorax 2002;57:374-375.
  103. Polvi A, Polvi T, Sevon P, Petäys T, Haahtela T, Laitinen LA, Kere J, Laitinen T: Physical map of an asthma susceptibility locus in 7p15-p14 and an association study of TCRG. Eur J Hum Genet 2002;10:658-665.
  104. Poodar T, Tuomilehto J: The role of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in the management of diabetic complications. DRUGS 2002;62:2007-2012.
  105. Puska P: Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland. Public Health Medicine 2002;4:5-7.
  106. Puska P, Korpelainen V, Hoie LH, Skovlund E, Lahti T, Smerud KT: Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial. Eur J Clin Nutr 2002;56:352-357.
  107. Puska P, Pietinen P, Uusitalo U: Part III. Can we turn back the clock or modify the adverse dynamics? Programme and policy issues. Influencing public nutrition for non-communicable disease prevention: from community intervention to national programme - experiences from Fin. Public health nutrition 2002;5:245-251.
  108. Qiao Q, Pyörälä K, Pyörälä M, Nissinen A, Lindström J, Tilvis R, Tuomilehto J: Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002;23:1267-1275.
  109. Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, Knip M, Jalkanen S, Salomaa V: Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. AM J PATHOL 2002;161:2255-2262.
  110. Salomaa V, Rasi V, Kulathinal S, Vahtera E, Jauhiainen M, Ehnholm C, Pekkanen J: Hemostatic factors as predictors of coronary events and total mortality. The FINRISK '92 Hemostasis Study. Arterioscler Thromb Vasc Biol 2002;22:353-358.
  111. Saukkonen T, Väisänen S, Åkerblom HK, Savilahti E: Coeliac disease in children and adolescents with type 1 diabetes: a study of growth, glycaemic control, and experiences of families. Acta Paediatr 2002;91:297-302.
  112. Shaltout AA, Moussa MA, Qabazard M, Abdella N, Karvonen M, Al-Khawari M, Al-Arouj M, Al-Nakhi A, Tuomilehto J, El-Gammal A: Further evidence for the rising incidence of childhood Type 1 diabetes in Kuwait. Diabet Med 2002;19:522-525.
  113. Slimani N, Valsta LM, The EFCOSUM Group: Perspectives of using the EPIC-SOFT programme in the context of pan-European nutritional monitoring surveys:, methodological and practical implications. Eur J Clin Nutr 2002;56(Suppl 2):S63-S74.
  114. Smith-Warner SA, Ritz J, Hunter DJ, Albanes D, Beeson WL, van den Brandt PA, Colditz G, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Kushi LH, Miller AB, Rohan TE, Speizer FE, Virtamo J, Willett WC: Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers Prev 2002;11:987-992.
  115. Staessen JA, Thijs L, O'Brien ET, Bulpitt CJ, De Leeuw PW, Fagard RH, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, Safar ME, SYST-EUR Trial Investigators: Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertnsion. AM J HYPERTENS 2002;15:835-843.
  116. Stengård JH, Clark AG, Weiss KM, Kardia S, Nickersson DA, Salomaa V, Ehnholm C, Boerwinkle E, Sing CF: Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet 2002;71:501-517.
  117. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D: A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 2002;13:417-426.
  118. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D: Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002;155:783-792.
  119. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D: Stolzenberg-Solomon et al. respond to 'What do we know about pancreas cancer?' by Potter. Am J Epidemiol 2002;155:796-797.
  120. Strandberg TE, Salomaa VV, Vanhanen HT, Pitkälä K, Miettinen TA: Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. J Hypertens 2002;20:399-404.
  121. Suojanen A, Raulio S, Ovaskainen M: Liberal fortification of foods: the risks. A study relating to Finland. J EPIDEMIOL COMMUNITY HEALTH 2002;56:259-264.
  122. The DECODA Study Group, Tuomilehto J, Qiao Q: Cardiovascular risk profile assessment in glucose-intolerant Asian individuals - an evaluation of the World Health Organization two-step strategy: the DECODA Study Group on behalf of the International Diabetes Epidemiology Group. Diabet Med 2002;19:549-557.
  123. The DECODE Study Group, Nissinen A, Pekkanen J, Tuomilehto J, Jousilahti P, Lindström J: Age, body mass index and glucose tolerance in 11 European population-based surveys. The DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabet Med 2002;19:558-565.
  124. Tolonen H, Mähönen M, Asplund K, Rastenyte D, Kuulasmaa K, Vanuzzo D, Tuomilehto J, for the WHO MONICA Project: Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? Stroke 2002;33:2367-2375.
  125. Tuomilehto J: Interrupting the atherosclerotic process in diabetes: When and how should we treat? Advanced Studies in Medicine 2002;2:800-807.
  126. Tuomilehto J: Point: A glucose tolerance test is important for clinical practice. Diabetes Care 2002;25:1880-1882.
  127. Vartiainen E, Petäys T, Haahtela T, Jousilahti P, Pekkanen J: Allergic diseases, skin prick test responses, and IgE levels in North Karelia, Finland, and the Republic of Karelia, Russia. J Allergy Clin Immunol 2002;109:643-648.
  128. Vartiainen E, Seppälä T, Lillsunde P, Puska P: Validation of self reported smoking by serum cotinine measurement in a community-based study. J EPIDEMIOL COMMUNITY HEALTH 2002;56:167-170.
  129. Vuorela P, Sarkola T, Alfthan H, Halmesmäki E: Hepatocyte growth factor, epidermal growth factor, and placenta growth factor concentrations in peripheral blood of pregnant women with alcohol abuse. Alcohol Clin Exp Res 2002;26:682-687.
  130. Woodson K, Triantos S, Hartman T, Taylor PR, Virtamo J, Albanes D: Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. Anticancer Res 2002;22:375-378.
  131. Yu Z, Nissinen A, Vartiainen E, Hu G, Tian H, Guo Z: Socio-economic status and serum lipids: A cross-sectional study in a Chinese urban population. J Clin Epidemiol 2002;55:143-149.

B. Original articles and reviews published in domestic languages

  1. Aro AR: Altistaako masennus rintasyövälle? Erikoislääkäri 2002;13:7-8.
  2. Eriksson J: Låg födelsevikt och sociala faktorer påverkar risken för koronarsjukdom. LAKARTIDNINGEN 2002;99:1209-1209.
  3. Jallinoja P: Genetiikka, etiikka ja moraalikysymysten yhteismitattomuus. Sosiologia 2002(4):274-284.
  4. Jula A, Aro A, Fyhrqvist F, Kantola I, Keinänen-Kiukaanniemi S, Koivisto P, Kukkonen-Harjula K, Luostarinen E, Majahalme S, Nieminen MS, Niskanen L, Nissinen A, Olkinuora J, Pentikäinen P, Pyörälä K, Romo M, Ruskoaho H, Takala J, Tikkanen T, Tikkanen I, Tuomilehto J, Turjanmaa V: Kohonneen verenpaineen hoito. Duodecim 2002;118:110-126.
  5. Ketonen M, Mustaniemi H, Palomäki P, Mustonen J, Lehto S, Miettinen H, Torppa J, Salomaa V: Äkilliset sepelvaltimotautikohtaukset Itä-Suomessa vuosina 1983-1992 (III). Kohtaustappavuus ja kuolemien ajoittuminen suhteessa oireiden ilmaantumiseen ja sairaalahoitoon Pohjois-Karjalan ja Pohjois-Savon sairaanhoitopiireissä. Suom Lääkäril 2002;57:3703-3708.
  6. Ketonen M, Mustaniemi H, Palomäki P, Mustonen J, Lehto S, Miettinen H, Torppa J, Salomaa V: Äkilliset sepelvaltimotautikohtaukset Itä-Suomessa vuosina 1983-1992 (IV). Sepelvaltimotautikuolleisuuden ja sydäninfarktin kohtaustaajuuden kuntakohtainen tarkastelu Pohjois-Karjalan ja Pohjois-Savon sairaanhoitopiireissä. Suom Lääkäril 2002;57:3839-3844.
  7. Ketonen M, Mustaniemi H, Palomäki P, Mustonen J, Lehto S, Miettinen H, Torppa J, Salomaa V: Äkilliset sepelvaltimotautikohtaukset Itä-Suomessa vuosina 1983-1992 (II). Hoidon porrastuksen toteutuminen ja siihen vaikuttavat tekijät Pohjois-Karjalan ja Pohjois-Savon sairaanhoitopiireissä. Suom Lääkäril 2002;57:3583-3590.
  8. Ketonen M, Mustaniemi H, Palomäki P, Mustonen J, Lehto S, Miettinen H, Torppa J, Salomaa V: Äkilliset sepelvaltimotautikohtaukset Itä-Suomessa vuosina 1983-1992 (I). Epidemiologinen tilanne ja kehitys Pohjois-Karjalan ja Pohjois-Savon sairaanhoitopiireissä pienalueittain tarkasteltuna. Suom Lääkäril 2002;57:3457-3464.
  9. Lahti-Koski M: Miehet lihavampia kuin koskaan, naistenkin vyötärölihavuus yleistyy. Suom Lääkäril 2002;57:1142-1143.
  10. Lahti-Koski M, Kolehmainen M, Karhunen L: Lihavuus yleistyy suomalaisilla ja tutkimusaiheena. Kehittyvä elintarvike 2002(2):8-9.
  11. Lindström J, Tuomilehto J: Tyypin 2 diabeteksen sairastumisriskin arviointi: Mihin riskitestilomake perustuu? Diabetes ja lääkäri 2002(2):16-19.
  12. Mikkilä V, Lahti-Koski M, Pietinen P, Virtanen SM, Rimpelä M: Nuorten lihavuuteen ja koettuun painoon liittyvät tekijät. Duodecim 2002;118:921-929.
  13. Patja K: Tupakointi ja aikuistyypin diabeteksen riski. Suom Lääkäril 2002;57:3855-3858.
  14. Salminen V, Lindström J, Louheranta A, Rastas M: Ruokavalio- ja liikuntaneuvonta ehkäisevät diabeteksen puhkeamista. Diabetes Prevention Study, DPS. Suom Lääkäril 2002;57:1379-1382.
  15. Salomaa V, Ketonen M, Koukkunen H, Immonen-Räihä P, Jerkkola T, Kärjä-Koskenkari P, Mähönen M, Kuulasmaa K, Mustonen J, Palomäki P, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Juolevi A, Torppa J, Tuomilehto J, Kesäniemi A, Pyörälä K: Sepelvaltimotautitapahtumien esiintyvyyden kehityssuunnat Suomessa 1993-1997. Suom Lääkäril 2002;57:3239-3244.
  16. Sivenius J, Jakovljevic D, Tuomilehto J, Sarti C, Torppa J, Mähönen M, Immonen-Räihä P, Kaarsalo E, Kuulasmaa , Alhainen K, Lehtonen A, Kaarisalo M, Salomaa V: Sosioekonomisen aseman yhteys aivoinfarktiin ja aivoverenvuotoon suomalaisessa aikuisväestössä. Suom Lääkäril 2002;57:627-633.
  17. Tuomilehto J: Aivoinfarktiriskin ennustamisen vaikeus. Duodecim 2002;118:2527-2530.
  18. Tuomilehto J: Valtakunnallinen tyypin 2 diabeteksen ehkäisyohjelma. Suomi suunnannäyttäjänä. Diabetes ja lääkäri 2002(2):10-15.
  19. Valle T, Lindström J, Eriksson J, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Louheranta A, Laakso M, Martikkala V, Rastas M, Salminen V, Aunola S, Hakumäki M, Mannelin M, Sundvall J, Uusitupa M, Tuomilehto J: Elämäntapamuutokset tehokkaita tyypin 2 diabeteksen ehkäisyssä. Diabetes Prevention Study, DPS. Suom Lääkäril 2002;57:1369-1378.
  20. Valsta L: Väriä elämään - puoli kiloa päivässä. Suom Lääkäril 2002;57:2667-2668.
  21. Winell K, Erhola M, Iivonen K, Kentala J, Koski K, Kukkonen-Harjula K, Patja K, Rautalahti M, Teräsalmi E, Vilkman S: Käypä hoito -suositus. Tupakointi, nikotiiniriippuvuus ja vieroitushoidot. Duodecim 2002;118:2578-2587.

C. Textbooks and chapters in textbooks, reports and proceedings

  1. Helakorpi S, Martelin T, Uutela A: Smoking behaviour in Finland and its associations with birth cohort and education, 1978-1996. In: Seventh International Congress of Behavioural Medicine. 2002:110. (International journal of behavioral medicine Vol 9 Suppl 1/2002).
  2. Helakorpi S, Patja K, Prättälä R, Aro AR, Uutela A: Suomalaisen aikuisväestön terveyskäyttäytyminen ja terveys, kevät 2002. Publications of National Public Health Institute, Series B 2002(B12).
  3. Jallinoja P, Helakorpi S, Uutela A: Suomalaisen aikuisväestön kontaktit huumeisiin ja mielipiteet huumeista vuonna 2001. Publications of National Public Health Institute, Series B 2002(B2).
  4. Kangas I, Keskimäki I, Koskinen S, Manderbacka K, Lahelma E, Prättälä R, Sihto M: Kohti terveyden tasa-arvoa. Helsinki: Edita Prima Oy, 2002. 333 p.
  5. Karvonen M, Tuomilehto J, Podar T: Epidemiology of type 1 diabetes. In: Textbook of Diabetes. Blackwell Science Ltd, 2002:51-514.
  6. Moller A, Saxholt E, Ovaskainen M, Knuts L, Reykdal O, Steingrimsdottir L, Haga RA, Bjorke LE, Becker W, Enghardt BH, Torelm I: Norfoods 2000 Intagsberäkningar av kostdata i Norden. 2002. (Tema Nord 2002:522).
  7. Ovaskainen ML, Reinivuo H, Korhonen T: Elintarviketaulukko. Tiedot ravintokoostumuksesta. 2.painos. Helsinki: Kansanterveyslaitos, Otava, 2002. 90 p.
  8. Prättälä R, Roos E, Roos G: Ravitsemuspolitiikka ja sosioekonomiset erot. In: Kangas I, Keskimäki I, Koskinen S, Manderbacka K, Lahelma E, Prättälä R, Sihto M ed. Kohti terveyden tasa-arvoa. Helsinki: Edita Prima Oy, 2002:67-81.
  9. Prättälä R, Roos G, Hulshof K, Sihto M: Food and nutrition policies and interventions. In: Mackenbach J, Bakker M, Benach J, Burström B, Dahl E, Judge K, Lahelma E, Östlin P, Stronks K, Whitehead M ed. Reducing inequalities in health a European perspective. London: Routledge, Taylor & Francis Group, 2002:105-124.
  10. Sandström P, Vartiainen ER, Pyykönen M, Nissinen A, Puska P: International Quit and Win 2000. Publications of National Public Health Institute, Series B 2002(B6):1-91.
  11. Tolonen H, Kuulasmaa K, Asplund K, Mähönen M, for the WHO MONICA Project: Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? 2002. (available from URL:http://www.ktl.fi/publications/monica/stroke_h1/appendix.htm, URN:NBN:fi-fe20021258 ).
  12. Tolonen H, Kuulasmaa K, Laatikainen T, Wolf H, the European Health Risk Monitoring Project: Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys.Available from http://www.ktl.fi/publications/ehrm/product2/title.htm. 2002.
  13. Tolonen H, Wolf H, Jakovljevic D, Kuulasmaa K, the European Health Risk Monitoring Project, Laatikainen T: Review of surveys for risk factors of major chronic diseases and comparability of the results. Available from http://www.ktl.fi/publications/ehrm/product1/title.htm. 2002.
  14. Tuomilehto J: Missed and newly recovered potential for the prevention of type 2 diabetes: A commentary. In: Williams R, Herman W, Kinmonth AL, Wareham NJ ed. The Evidence Base for Diabetes Care. John Wiley & Sons Ltd, 2002:177-187.
  15. Uusitalo U, Pietinen P, Puska P: Dietary transition in developing countries: challenges for chronic disease prevention. In: Globalization, diets and noncommunicable diseases. Geneva: WHO, 2002.
  16. Uusitalo U, Pietinen P, Puska P, Chopra M, Tullao TS, Wahlqvist M, Wattanapenpaiboon N, Hawkes C: Globalization, diets and noncommunicable diseases. Switzerland: World Health Organization, 2002. 78 p.
  17. the European Health Risk Monitoring Project: Health Surveys in Europe. The Role of Surveys in Monitoring. 2002. (Available from http://www.ktl.fi/publications/ehrm/product4/report.htm).

D. Other publications

  1. Jallinoja P: Iina Hellsten: The politics of metaphor. Biotechnology and biodiversity in the media (Book review). 2002. (Tiedotustutkimus 2002:4:96).
  2. Laatikainen T, Haukkala A, Ravlija J, Omanic J, Filipovic-Hadziomeragic A, Vilic-Svraka A, Mulaomerovic M, Zeljko M: Health behaviour in school-aged children survey: Federation of Bosnia and Herzegovina 2002. 2002. (Publication of the Institute of Public Health of the Federation of Bosnia and Herzegovina).
  3. Laatikainen T, Haukkala A, Ravlija J, Omanic J, Filipovic-Hadziomeragic A, Vilic-Svraka A, Mulaomerovic M, Zeljko M: Non-communicable diseases risk factor survey: Federation of Bosnia and Herzegovina 2002. 2002. (Publication of the Institute of Public Health of the Federation of Bosnia and Herzegovina).
  4. Lallukka T, Ovaskainen M: Nuorten aikuisten kasvisten käyttö suosituksia vähäisempää. 2002. (Kansanterveyslehti 4/2002).
  5. Sandström P: Voinko auttaa potilastani lopettamaan tupakoinnin? 2002. (Terveyssanomat 2/2002).
  6. Tuomilehto J: Suolan käyttö sydän- ja verisuonitautien vaaratekijänä. 2002. (Pansuola sanomat 2002:3-4).

E. Theses

  1. Absetz P: Determinants and psychological implications of breast cancer risk perceptions in the course of mammography screening. Publications of National Public Health Institute, Series A 2002(18):1-73.
  2. Haukkala A: Depressive symptoms and hostility in relation to socioeconomic status, smoking cessation, and obesity. Helsinki: Yliopistopaino, 2002. 133 p. (Publications of the National Public Health Institute A 14/2002).
  3. Jallinoja P: Genetics, negotiated ethics and the ambiguities of moral choices. Publications of National Public Health Institute, Series A 2002(2).
  4. Laaksonen M: Interrlationships among daily health behaviours: Towards health-related lifestyle. Publications of National Public Health Institute, Series A 2002(6):1-71.
  5. Leppälä JM: Risk factors for stroke: Bayesian versus frequentist analysis (Dissertation for the Doctor of Philosophy in Epidemiology). Los Angeles: University of California, 2002.